Natural Agents That May Benefit Pancreatic Cancer Patients
Lucas Figueroa is a Licensed Naturopath practicing in Puerto Rico and Texas, specializes in proactive prevention and treatment, combining holistic healing methods with traditional solutions to medical illness. Providing both individual and family care, the most common ailments treated are cancer, chronic, autoimmune, inflammatory,... more
There are many natural agents that can help pancreatic cancer patients. These include Vitamins A, D, E (delta tocotrienol), K and B12, as well as minerals selenium, zinc, magnesium, calcium, and iron. Probiotics, prebiotics, and phytonutrients against the dysbiosis caused by the allopathic therapies. Also, proanthocyanidins, polyphenols (catechins), and antioxidants.
Melatonin supplementation shows promise for cancer patients who are also receiving chemotherapy, radiotherapy, supportive therapy, or palliative therapy. Omega-3 (polyunsaturated fatty acids DHA and EPA) are reported to improve clinical outcomes and prognosis in pancreatic cancer patients. Viscum album (mistletoe) gemmotherapy is a potentially effective adjunct or second-line therapy that may prolong overall survival and reduce disease-related symptoms.
L-carnitine treatment is reported to improve nutritional status and reduce weight loss. Homeopathy Psorinum and Lycopodium (concurrent with supportive care) as a primary treatment for patients with advanced liver, pancreatic, gastric, and gallbladder cancers reported some tumor response and survival benefit.
Cannabinoid is beneficial for insomnia, pain, and fatigue. Vitamin D3/K2 treatment is used for cancer-related symptom management. Sun exposure is important to maintain vitamin D levels in patients, deficiency increases the risk of cancer. Dietary fibers such as pectin and cellulose may decrease primary bile acid effects or decrease secondary bile acid concentrations in fecal water, thereby reducing the fecal water toxicity that leads to diarrhea.
The Mediterranean, Gerson, and Keto diets have been shown to decrease markers related to metabolic syndrome (high-sensitivity C-reactive protein [hs-CRP], interleukin [IL]-7, IL-18, and insulin resistance). These markers are associated with increased cancer incidence and cancer-related mortality, and are related to inflammation and lipid oxidation.
The trypsin structure is a dissolve envelope that protects the cancer cells, and the raw pancreas tissue.
